2.55500 EUR
0.01
0.39%
Last update Dec 15, 8:13 AM CET
Main market
Day range
2.55500
2.55500
Previous close
2.54500
Open
2.55500
Access this stock data via API
Subscribe
BioInvent International AB
2.56
0.01
0.39%

Financials

Income statement

Fundamentals currency is SEK
Fiscal date 2024 2023 2022 2021
Total reported revenue 4.1M 71.5M 29.1M 1.7M
Cost of revenue
Gross profit
Operating expense
Research & development 42.1M 390.4M 29.1M 23.0M
Selling general and admin 5.4M 51.6M 4.5M 3.5M
Other operating expenses -26.7K
Operating income -43.3M -370.6M -4.5M -24.8M
Non operating interest income
Income 3.9M 40.6M 808.9K 23.5K
Expense 51.0K 638K 58.0K 46.1K
Other income expense
Pretax income -39.5M -330.1M -3.8M -24.8M
Tax provision 12.4K 204K 0 0
Net income -39.5M -330.3M -3.8M -24.8M
Basic EPS -6.5 -5.0 -0.7 -5.1
Diluted EPS -6.5 -5.0 -0.7 -5.1
Basic average shares 6.0M 726.4M 61.5M 54.2M
Diluted average shares 6.0M 726.4M 61.5M 54.2M
EBITDA -38.4M -312.7M -2.4M -23.5M
Net income from continuing op. -43.3M -369.9M -4.5M -24.8M
Minority interests
Preferred stock dividends 0 0 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 13 hours 42 minutes

08:17
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).